Cancer, Solid tumor/s
TCRXTScan TherapeuticsCatalyst overview
Research summary
This catalyst tracks a Failed discontinued for TSC-203-A0201, TSC-200-A0201, TSC-204-A0201, TSC-204-C0702,TSC-201-B0702, TSC-204-A0101 in Cancer, Solid tumor/s. The expected timing is based on the latest available company guidance and may change.
PLEXI-T solid tumor trial. 12/10/24- Provided update on PLEXI-T Ph1 trial. 11/3/25- Further enrollment paused with planned data in Q1 2026. 11/12/25:- Enrollment remains paused; plan to share safety and efficacy data in Q1 2026. 03/04/26:- PLEXI-T Ph1 trial discontinued; initial patient data disclosed in 2025 Form 10-K.
Verification
Confirm timing and program details against the company announcement or filing.